Peter Dreier and Donald Cohen: It is time for Congress to put the cop on this pharmaceutical beat before more Americans die from the profits-over-safety priorities of this rogue industry.
Marian Wang: Pfizer is adding yet another twist to its efforts to delay generic competitors. As The New York Times reports, the company seems to have struck a deal with certain pharmacy benefit managers to block generic versions of Lipitor.
Wendy McElroy: A new slate of drugs now addresses a wide range of so-called disorders, or dysfunctions, that former generations considered environmental problems or lifestyle choices: from obesity to attention deficit, from erectile dysfunction to social anxiety (shyness), from menopause to alcoholism.
Tracy Emblem: Up to 40% of the drugs Americans take are now imported, and up to 80% of the active pharmaceutical ingredients in drugs are manufactured by companies in foreign countries.
Senator Joe Lieberman continues to threaten filibuster of the Senate health reform bill even in the face of the recent Harvard study showing that 45 thousand Americans die each year because of lack of sufficient health care.
The current state of the health care “debate” illustrates, even with the election of Barack Obama and large Democratic majorities in Congress, we might have already lost the vocabulary for collective moral discourse.
The White House confirmed it has promised Big Pharma that any healthcare legislation will bar the government from using its huge purchasing power to negotiate lower drug prices. That’s basically the same deal George W. Bush struck in getting the Medicare drug benefit.
Frequently of late it seems that CNN provides an inordinate amount of time for the Republican Congressional Leadership to vilify The President’s attempts to care for the poor, the helpless and the infirm. As I watch these folks babbling away, I am reminded of a comment that Mark Twain wrote in the New York Tribune, […]